IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $988,257 | -14.7% | 62,272 | +1.4% | 0.01% | -11.1% |
| Q2 2023 | $1,159,184 | +424.4% | 61,430 | +6.7% | 0.01% | +350.0% |
| Q1 2023 | $221,057 | -20.5% | 57,567 | +2.7% | 0.00% | -33.3% |
| Q4 2022 | $278,018 | +7.8% | 56,052 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $258,000 | +6.6% | 53,937 | +0.3% | 0.00% | +50.0% |
| Q2 2022 | $242,000 | -7.3% | 53,788 | -1.8% | 0.00% | 0.0% |
| Q1 2022 | $261,000 | -35.4% | 54,771 | +0.5% | 0.00% | -33.3% |
| Q4 2021 | $404,000 | +30.7% | 54,477 | +0.0% | 0.00% | 0.0% |
| Q3 2021 | $309,000 | -11.5% | 54,463 | +2.9% | 0.00% | 0.0% |
| Q2 2021 | $349,000 | -21.0% | 52,927 | -3.0% | 0.00% | -25.0% |
| Q1 2021 | $442,000 | +35.2% | 54,590 | +7.8% | 0.00% | +33.3% |
| Q4 2020 | $327,000 | +73.0% | 50,640 | -3.8% | 0.00% | +50.0% |
| Q3 2020 | $189,000 | +4.4% | 52,623 | +33.8% | 0.00% | -33.3% |
| Q2 2020 | $181,000 | +32.1% | 39,323 | -2.1% | 0.00% | +50.0% |
| Q1 2020 | $137,000 | – | 40,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |